Loading
Cancer and its treatment
Treatment rather than the cancer carries most of the sexual impact here: chemotherapy can trigger an abrupt early menopause, endocrine therapy suppresses or blocks oestrogen for five to ten years, and surgery changes sensation and body image. The result is dryness and painful sex that are close to universal, often severe, and — crucially — treatable, though they are frequently presented as the price of survival.
See someone about this if
Editorial categories, not percentages, and never a prediction about you. Each links to the fuller picture of that change.
Less natural lubrication, a tight or raw feeling, or discomfort that arrives during rather than before sex. Medicines cause this either by drying mucous membranes generally or by lowering oestrogen.
Burning, tearing, or aching pain with penetration. Pain is never a symptom to work around with a product — it is the one entry on this list that always deserves assessment.
Wanting sex less often, or losing the spontaneous interest that used to arrive on its own. This is the effect people most often assume is psychological and most often is not only psychological.
The body responds less, or much more slowly, even when the interest is there. Blood flow, nerve signalling, and hormone levels all feed this, and medicines can act on any of the three.
Sex stops happening because there is nothing left in the tank by the time there is an opportunity. A real medicine effect, not a motivation problem.
Arousal works but orgasm does not arrive. When this starts within weeks of a new medicine and had never happened before, the timing itself is information.
Condition or treatment?
Aromatase inhibitors drive oestrogen lower than natural menopause does, tamoxifen blocks it at the receptor, and SSRIs are often added for hot flushes — bringing their own orgasm effects. Each of these has a different profile, and knowing which one you are on changes both what to expect and what can be offered.
For almost every condition on this site, the condition and the medicines that treat it both affect sex — by different mechanisms, on different timescales, and with different answers. Being able to say which half you are asking about is the single most useful thing you can bring to an appointment, and it is the thing patients are least often given.
Never stop, pause, reduce, or change a prescribed medicine because of anything on this page. Some of the medicines listed here are dangerous to stop suddenly, and the condition being treated does not pause while you experiment. Everything here exists to make your next conversation with a prescriber more specific — not to replace it.
Matters more if: menopause-related dryness; sensitive or irritation-prone.
Treatment rather than the cancer carries most of the sexual impact here: chemotherapy can trigger an abrupt early menopause, endocrine therapy suppresses or blocks oestrogen for five to ten years, and surgery changes sensation and body image. The result is dryness and painful sex that are close to universal, often severe, and — crucially — treatable, though they are frequently presented as the price of survival.
The effects reported most often are vaginal dryness or less natural lubrication, pain during penetration, lower sexual desire, arousal is slower or harder to reach, and fatigue or sedation getting in the way. Reported does not mean inevitable — the picture varies a great deal between people, and most people have more than one thing contributing at once.
Aromatase inhibitors drive oestrogen lower than natural menopause does, tamoxifen blocks it at the receptor, and SSRIs are often added for hot flushes — bringing their own orgasm effects. Each of these has a different profile, and knowing which one you are on changes both what to expect and what can be offered. Timing is the most useful clue you have: an effect that appeared within weeks of starting or changing a treatment points at the treatment, while one that predates it points at the condition. Never stop, pause, or change a prescribed treatment to find out — take the timeline to the person who prescribed it.
The classes commonly used here that carry documented sexual effects are tamoxifen, aromatase inhibitors, gnrh analogues, cytotoxic chemotherapy, and ssri antidepressants. Each has its own profile, so which one you are on matters — and that is a prescribing conversation, never a reason to stop anything.
A regular vaginal moisturiser on a schedule plus a glycerin-free or silicone lubricant for sex; oncology guidance describes the combination, not either alone. Vaginal dilators and pelvic-floor physiotherapy are standard parts of care here and are routinely under-offered — ask by name. Menopause-after-cancer and psychosexual services exist in many centres; ask whether yours has one.
Sooner than most people do, and specifically without waiting: Any unexpected vaginal bleeding on endocrine therapy needs prompt assessment.
Educational information about what a diagnosed condition tends to do — not a diagnosis, not a way to work out whether you have something, and not advice about your treatment. Conditions on this page overlap, and most people with a long-term condition have more than one thing affecting them at once. Nothing here can examine you or run a test. Pain, bleeding, or a new and unexplained symptom always deserves assessment.